CARCINOMA, NON-SMALL-CELL LUNG
Clinical trials for CARCINOMA, NON-SMALL-CELL LUNG explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, NON-SMALL-CELL LUNG trials appear
Sign up with your email to follow new studies for CARCINOMA, NON-SMALL-CELL LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo aims to shrink lung tumors before surgery
Disease control Not yet recruitingThis study tests whether giving a combination of drugs (amivantamab plus lazertinib or chemotherapy) before surgery can shrink or stop the growth of a specific type of lung cancer (EGFR-mutated non-small cell lung cancer). About 68 people with stage II to IIIB cancer that can be …
Matched conditions: CARCINOMA, NON-SMALL-CELL LUNG
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 26, 2026 04:42 UTC
-
Could a cheaper keytruda copy work just as well for lung cancer?
Disease control Not yet recruitingThis study tests whether a biosimilar called QL2107 works the same as the drug Keytruda (pembrolizumab) when given after surgery for non-small cell lung cancer. About 122 adults with stage II or IIIA lung cancer who have already had surgery and chemotherapy will receive either QL…
Matched conditions: CARCINOMA, NON-SMALL-CELL LUNG
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Can less lung surgery after immunotherapy be just as safe?
Disease control Not yet recruitingThis study looks at people with stage II to IIIB non-small cell lung cancer whose tumors shrank after immunotherapy. It compares two surgery approaches: removing only the shrunken tumor area versus removing the original larger area. The goal is to see if less surgery can preserve…
Matched conditions: CARCINOMA, NON-SMALL-CELL LUNG
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Could existing melanoma drugs work for other rare cancers? new trial aims to find out.
Disease control Not yet recruitingThis trial tests whether two drugs already approved for certain skin and lung cancers can help people with rare cancers that have a specific gene change called BRAF V600. About 30 adults and children with various rare cancers will receive dabrafenib and trametinib. The goal is to…
Matched conditions: CARCINOMA, NON-SMALL-CELL LUNG
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated May 26, 2026 04:31 UTC
-
Smart MRI could shield lungs during cancer radiation
Symptom relief Not yet recruitingThis study tests a new way to plan radiation treatment for non-small cell lung cancer. Doctors will use a special MRI scan (hyperpolarized xenon MRI) to see which parts of the lungs are working well and which are not. They then aim to avoid radiating healthy lung areas, which may…
Matched conditions: CARCINOMA, NON-SMALL-CELL LUNG
Phase: PHASE1, PHASE2 • Sponsor: Xemed LLC • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC